Showcases Stock ranks Forex

Elanco Animal Health Inc (ELAN)
8.82  0.03 (0.34%) 03-24 16:00
Open: 8.695 Pre. Close: 8.79
High: 8.97 Low: 8.68
Volume: 12,645,423 Market Cap: 4,522(M)
Stock Technical Analysis
Target: Six months: 13.45
One year: 15.50
Support: Support1: 8.68
Support2: 7.22
Resistance: Resistance1: 11.52
Resistance2: 13.27
Pivot: 9.62
Moving Averages: MA(5): 9.10
MA(20): 10.04
MA(100): 12.23
MA(250): 16.59
MACD: MACD(12,26): -0.88
Signal(12,26,9): -0.85
%K %D: %K(14,3): 2.79
%D(3): 6.43
RSI: RSI(14): 24.78
52-Week: High: 27.68
Low: 8.68
Change(%): -67.5
Average Vol(K): 3-Month: 7695
10-Days: 11601
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 8.974 - 9.019 9.019 - 9.064
Low: 8.577 - 8.622 8.622 - 8.668
Close: 8.747 - 8.819 8.819 - 8.892
Price, MAs and Bollinger Bands
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.

[ ELAN ] has closed above bottom band by 17.7%. Bollinger Bands are 16% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Company profile
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Stock chart
Stock News
Fri, 24 Mar 2023
A Look at Elanco Animal Health Incorporated (ELAN) Shares in the ... - SETE News

Thu, 23 Mar 2023
Douglas Lane & Associates LLC Sells 234635 Shares of Elanco ... - MarketBeat

Wed, 22 Mar 2023
Future Outlook And Elanco Animal Health Incorporated Stock Price ... - Marketing Sentinel

Tue, 21 Mar 2023
Sanders Morris Harris LLC increases its stake in Elanco Animal ... - Best Stocks

Tue, 21 Mar 2023
Sanders Morris Harris LLC Boosts Holdings in Elanco Animal Health ... - MarketBeat

Fri, 17 Mar 2023
Robeco Institutional Asset Management B.V. Increases Stake in ... - MarketBeat

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 491.54
Shares Float (M) 489.59
% Held by Insiders 0.35
% Held by Institutions 100.12
Shares Short (K) 13950
Shares Short Prior Month (K) 21170
Stock Financials
EPS -0.160
Book Value (p.s.) 15.370
Profit Margin -1.77
Operating Margin 8.84
Return on Assets (ttm) 1.5
Return on Equity (ttm)
Qtrly Rev. Growth -11.8
Gross Profit (p.s.) 5.086
Sales Per Share 8.972
EBITDA (p.s.) 2.055
Qtrly Earnings Growth
Operating Cash Flow (M) 452.00
Levered Free Cash Flow (M) 330.12
Stock Valuation
PE Ratio -55.13
PEG Ratio 1.79
Price to Book value 0.57
Price to Sales 0.98
Price to Cash Flow 9.59
Stock Dividends
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android